Chargement en cours...
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016
For regulatory approval of a new medicine, the gold standard for demonstration of efficacy has traditionally been a minimum of two positive, adequate, and well‐controlled clinical trials. Nevertheless, drugs to treat cancer and rare diseases are usually approved based on a single and often uncontrol...
Enregistré dans:
| Publié dans: | Clin Transl Sci |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662549/ https://ncbi.nlm.nih.gov/pubmed/30681284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12617 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|